Terms: = Endocrine gland cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR
91 results:
1. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian cancer.
Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
[TBL] [Abstract] [Full Text] [Related]
2. foxo1 promotes ovarian cancer by increasing transcription and METTL14-mediated m
Tan L; Wang S; Huang S; Tie Y; Sai N; Mao Y; Zhao S; Hou Y; Dou H
Cancer Sci; 2024 Apr; 115(4):1224-1240. PubMed ID: 38403332
[TBL] [Abstract] [Full Text] [Related]
3. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
4. Sertoli Cell-Specific Activation of Transforming Growth Factor Beta Receptor 1 Leads to Testicular Granulosa Cell Tumor Formation.
Fang X; Nie L; Putluri S; Ni N; Bartholin L; Li Q
Cells; 2023 Nov; 12(23):. PubMed ID: 38067144
[TBL] [Abstract] [Full Text] [Related]
5. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
6. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract] [Full Text] [Related]
7. Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas cancer via Crosstalk with AKT Signaling.
Li D; Miermont AM; Sable R; Quadri HS; Mathews Griner LA; Martin SE; Odzorig T; De S; Ferrer M; Powers AS; Hewitt SM; Rudloff U
Mol Cancer Res; 2023 Apr; 21(4):316-331. PubMed ID: 36790955
[TBL] [Abstract] [Full Text] [Related]
8. Online calculator for predicting the risk of malignancy in patients with pancreatic cystic neoplasms: A multicenter, retrospective study.
Jiang D; Chen ZX; Ma FX; Gong YY; Pu T; Chen JM; Liu XQ; Zhao YJ; Xie K; Hou H; Wang C; Geng XP; Liu FB
World J Gastroenterol; 2022 Oct; 28(37):5469-5482. PubMed ID: 36312834
[TBL] [Abstract] [Full Text] [Related]
9. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
10. Phosphoproteomic studies of alamandine signaling in CHO-MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled.
da Silva FA; Rodrigues-Ribeiro L; Melo-Braga MN; Passos-Silva DG; Sampaio WO; Gorshkov V; Kjeldsen F; Verano-Braga T; Santos RAS
Proteomics; 2022 Sep; 22(17):e2100255. PubMed ID: 35652611
[TBL] [Abstract] [Full Text] [Related]
11. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting foxo1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract] [Full Text] [Related]
12. Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/fkhr pathway.
Xu Z; Liu X; Zhuang D
Biochem Cell Biol; 2022 Feb; 100(1):85-92. PubMed ID: 34797728
[TBL] [Abstract] [Full Text] [Related]
13. Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer.
Safe S; Shrestha R; Mohankumar K; Howard M; Hedrick E; Abdelrahim M
World J Gastroenterol; 2021 Oct; 27(38):6387-6398. PubMed ID: 34720529
[TBL] [Abstract] [Full Text] [Related]
14. Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/foxo1 signaling.
Lang X; Chen Z; Yang X; Yan Q; Xu M; Liu W; He Q; Zhang Y; Cheng W; Zhao W
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22870. PubMed ID: 34350670
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes.
Ghaffarnia R; Nasrollahzadeh A; Bashash D; Nasrollahzadeh N; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2021 Oct; 908():174345. PubMed ID: 34270986
[TBL] [Abstract] [Full Text] [Related]
16. Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer.
Shi YY; Meng XT; Xu YN; Tian XJ
J Obstet Gynaecol Res; 2021 Jun; 47(6):1946-1957. PubMed ID: 33827148
[TBL] [Abstract] [Full Text] [Related]
17. foxo1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract] [Full Text] [Related]
18. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line.
Nozhat Z; Zarkesh M; Baldini E; Mohammadi-Yeganeh S; Azizi F; Hedayati M
Anticancer Agents Med Chem; 2022; 22(4):713-720. PubMed ID: 33461474
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines.
Fabi F; Adam P; Parent S; Tardif L; Cadrin M; Asselin E
Mol Oncol; 2021 Aug; 15(8):2106-2119. PubMed ID: 33338300
[TBL] [Abstract] [Full Text] [Related]
20. foxo1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.
Liu L; Yi J; Yuan J; Yao T; Lin Z; Ning Y; Zeng Z
Cancer Biomark; 2020; 28(1):1-8. PubMed ID: 32224523
[TBL] [Abstract] [Full Text] [Related]
[Next]
